Skip to main content
Top
Published in: Indian Journal of Gastroenterology 5/2023

15-06-2023 | Gallbladder Cancer | Original Article

Gastrointestinal involvement in gallbladder cancer: Computed tomography findings and proposal of a classification system

Authors: Raghuraman Soundararajan, Srivardhan Vanka, Pankaj Gupta, Manika Chhabra, Pratyaksha Rana, Ajay Gulati, Chandan K. Das, Parikshaa Gupta, Uma Nahar Saikia, Thakur Deen Yadav, Vikas Gupta, Lileswar Kaman, Harjeet Singh, Santosh Irrinki, Usha Dutta, Manavjit Singh Sandhu

Published in: Indian Journal of Gastroenterology | Issue 5/2023

Login to get access

Abstract

Background

There is relatively scarce data on the computed tomography (CT) detection of gastrointestinal (GI) involvement in gallbladder cancer (GBC). We aim to assess the GI involvement in GBC on CT and propose a CT-based classification.

Methods

This retrospective study comprized consecutive patients with GBC who underwent contrast-enhanced computed tomography (CECT) for staging between January 2019 and April 2022. Two radiologists evaluated the CT images independently for the morphological type of GBC and the presence of GI involvement. GI involvement was classified into probable involvement, definite involvement and GI fistulization. The incidence of GI involvement and the association of GI involvement with the morphological type of GBC was evaluated. In addition, the inter-observer agreement for GI involvement was assessed.

Results

Over the study period, 260 patients with GBC were evaluated. Forty-three (16.5%) patients had GI involvement. Probable GI involvement, definite GI involvement and GI fistulization were seen in 18 (41.9%), 19 (44.2%) and six (13.9%) patients, respectively. Duodenum was the most common site of involvement (55.8%), followed by hepatic flexure (23.3%), antropyloric region (9.3%) and transverse colon (2.3%). There was no association between GI involvement and morphological type of GBC. There was substantial to near-perfect agreement between the two radiologists for the overall GI involvement (k = 0.790), definite GI involvement (k = 0.815) and GI fistulization (k = 0.943). There was moderate agreement (k = 0.567) for probable GI involvement.

Conclusion

GBC frequently involves the GI tract and CT can be used to categorize the GI involvement. However, the proposed CT classification needs validation.
Literature
1.
go back to reference Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 2019;8:33.CrossRefPubMed Dutta U, Bush N, Kalsi D, Popli P, Kapoor VK. Epidemiology of gallbladder cancer in India. Chin Clin Oncol. 2019;8:33.CrossRefPubMed
5.
go back to reference Gupta P, Dutta U, Rana P, et al. Gallbladder reporting and data system (GB-RADS) for risk stratification of gallbladder wall thickening on ultrasonography: an international expert consensus. Abdom Radiol (NY). 2022;47:554–65.CrossRefPubMed Gupta P, Dutta U, Rana P, et al. Gallbladder reporting and data system (GB-RADS) for risk stratification of gallbladder wall thickening on ultrasonography: an international expert consensus. Abdom Radiol (NY). 2022;47:554–65.CrossRefPubMed
6.
go back to reference Gupta P, Meghashyam K, Marodia Y, et al. Locally advanced gallbladder cancer: a review of the criteria and role of imaging. Abdom Radiol (NY). 2021;46:998–1007.CrossRefPubMed Gupta P, Meghashyam K, Marodia Y, et al. Locally advanced gallbladder cancer: a review of the criteria and role of imaging. Abdom Radiol (NY). 2021;46:998–1007.CrossRefPubMed
7.
go back to reference Marodia Y, Kharel J, Saikia UN, et al. Association of CT findings with perineural invasion in gallbladder cancer: preliminary assessment. AJR Am J Roentgenol. 2022;9:1–2. Marodia Y, Kharel J, Saikia UN, et al. Association of CT findings with perineural invasion in gallbladder cancer: preliminary assessment. AJR Am J Roentgenol. 2022;9:1–2.
8.
go back to reference Choi SY, Kim JH, Lim S, Lee JE, Park HJ, Lee B. CT-based nomogram for predicting survival after R0 resection in patients with gallbladder cancer: a retrospective multicenter analysis. Eur Radiol. 2021;31:3336–46.CrossRefPubMed Choi SY, Kim JH, Lim S, Lee JE, Park HJ, Lee B. CT-based nomogram for predicting survival after R0 resection in patients with gallbladder cancer: a retrospective multicenter analysis. Eur Radiol. 2021;31:3336–46.CrossRefPubMed
9.
go back to reference Choi SY, Kim JH, Park HJ, Han JK. Preoperative CT findings for prediction of resectability in patients with gallbladder cancer. Eur Radiol. 201929:6458–68. Choi SY, Kim JH, Park HJ, Han JK. Preoperative CT findings for prediction of resectability in patients with gallbladder cancer. Eur Radiol. 201929:6458–68.
10.
go back to reference Boccatonda A, Cocco G, D’Ardes D, Schiavone C. GB-RADS score, a possible role for CEUS? Abdom Radiol (NY). 2023;48:1199–201.PubMed Boccatonda A, Cocco G, D’Ardes D, Schiavone C. GB-RADS score, a possible role for CEUS? Abdom Radiol (NY). 2023;48:1199–201.PubMed
11.
go back to reference Kalra N, Suri S, Gupta R, et al. MDCT in the staging of gallbladder carcinoma. AJR Am J Roentgenol. 2006;186:758–62.CrossRefPubMed Kalra N, Suri S, Gupta R, et al. MDCT in the staging of gallbladder carcinoma. AJR Am J Roentgenol. 2006;186:758–62.CrossRefPubMed
12.
go back to reference Kim SJ, Lee JM, Lee JY, et al. Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT. AJR Am J Roentgenol. 2008;190:74–80.CrossRefPubMed Kim SJ, Lee JM, Lee JY, et al. Accuracy of preoperative T-staging of gallbladder carcinoma using MDCT. AJR Am J Roentgenol. 2008;190:74–80.CrossRefPubMed
13.
go back to reference Agarwal AK, Mandal S, Singh S, Sakhuja P, Puri S. Gallbladder cancer with duodenal infiltration: is it still resectable? J Gastrointest Surg. 2007;11:1722–7.CrossRefPubMed Agarwal AK, Mandal S, Singh S, Sakhuja P, Puri S. Gallbladder cancer with duodenal infiltration: is it still resectable? J Gastrointest Surg. 2007;11:1722–7.CrossRefPubMed
14.
go back to reference Kalayarasan R, Javed A, Puri AS, Puri SK, Sakhuja P, Agarwal AK. A prospective analysis of the preoperative assessment of duodenal involvement in gallbladder cancer. HPB (Oxford). 2013;15:203–9.CrossRefPubMed Kalayarasan R, Javed A, Puri AS, Puri SK, Sakhuja P, Agarwal AK. A prospective analysis of the preoperative assessment of duodenal involvement in gallbladder cancer. HPB (Oxford). 2013;15:203–9.CrossRefPubMed
16.
go back to reference Dwivedi AND, Jain S, Dixit R. Gall bladder carcinoma: aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases. 2015;3:231–44.CrossRefPubMedPubMedCentral Dwivedi AND, Jain S, Dixit R. Gall bladder carcinoma: aggressive malignancy with protean loco-regional and distant spread. World J Clin Cases. 2015;3:231–44.CrossRefPubMedPubMedCentral
17.
go back to reference Scheingraber S, Justinger C, Stremovskaia T, Weinrich M, Igna D, Schilling MK. The standardized surgical approach improves outcome of gallbladder cancer. World J Surg Oncol. 2007;5:55.CrossRefPubMedPubMedCentral Scheingraber S, Justinger C, Stremovskaia T, Weinrich M, Igna D, Schilling MK. The standardized surgical approach improves outcome of gallbladder cancer. World J Surg Oncol. 2007;5:55.CrossRefPubMedPubMedCentral
Metadata
Title
Gastrointestinal involvement in gallbladder cancer: Computed tomography findings and proposal of a classification system
Authors
Raghuraman Soundararajan
Srivardhan Vanka
Pankaj Gupta
Manika Chhabra
Pratyaksha Rana
Ajay Gulati
Chandan K. Das
Parikshaa Gupta
Uma Nahar Saikia
Thakur Deen Yadav
Vikas Gupta
Lileswar Kaman
Harjeet Singh
Santosh Irrinki
Usha Dutta
Manavjit Singh Sandhu
Publication date
15-06-2023
Publisher
Springer India
Published in
Indian Journal of Gastroenterology / Issue 5/2023
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-023-01388-y

Other articles of this Issue 5/2023

Indian Journal of Gastroenterology 5/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine